30 Day Trial

aap Implantate's New U.S. Distribution Contract for LOQTEQ Products

Share:

aap Implantate entered into a distribution contract for LOQTEQ® trauma products with an unnamed U.S. healthcare service provider.

Per contract terms, a 12-month pilot phase allows the partner to sell LOQTEQ products in select U.S. regions. If successful, distribution will roll out to additional states. In the U.S., aap employs a hybrid distribution strategy via distribution agents and partnerships with global orthopaedic and medical technology companies.

In North America, aap's 3Q15 sales to local distributors and global partners grew to ~$0.75MM, up from ~$0.11MM in 3Q15.

Sources: aap Implantate AG; ORTHOWORLD Inc.